Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2021 0 · FY2022 0 · FY2023 0
Georgian medical clinic.
Subsidiary of EVEX Hospitals (100.0%)
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Margins | ||||||
| Gross Margin | 55.3% | 47.7% | 35.5% | 36.2% | 32.9% | 29.1% |
| EBITDA Margin | 42.1% | 34.9% | 21.9% | 24.3% | 18.6% | 14.0% |
| EBITDAR | 1,962 | 1,392 | 844 | 1,202 | 805 | 606 |
| EBITDAR Margin | 42.3% | 35.3% | 22.1% | 24.4% | 18.8% | 14.3% |
| EBIT Margin | 38.3% | 28.4% | 8.6% | 18.8% | 5.4% | 3.1% |
| Net Profit Margin | 42.7% | 34.2% | 21.5% | 29.8% | 18.1% | 13.3% |
| Operating Expense % of Sales | 13.2% | 12.8% | 13.6% | 12.1% | 16.3% | 15.3% |
| Returns | ||||||
| Return on Assets (ROA) | 27.3% | 13.4% | 7.0% | 11.5% | 5.5% | 5.4% |
| Return on Equity (ROE) | 42.4% | 22.4% | 12.3% | 18.1% | 8.7% | 6.0% |
| ROIC [EBIT / Invested Capital] | 38.2% | 19.0% | 5.3% | 12.0% | 2.7% | 1.4% |
| Leverage & debt balances | ||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 64.5% | 59.6% | 57.0% | 63.4% | 63.4% | 90.4% |
| Net Debt | -18 | -120 | -396 | -390 | -337 | -227 |
| Cash & Equivalents | 18 | 120 | 396 | 390 | 337 | 227 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||||
| Current Ratio | 0.79x | 0.65x | 0.60x | 0.83x | 1.07x | 2.26x |
| Quick Ratio | 0.79x | 0.61x | 0.54x | 0.77x | 1.03x | 2.09x |
| Cash Ratio | 0.01x | 0.03x | 0.08x | 0.08x | 0.07x | 0.23x |
| Total Current Assets | 1,756 | 2,644 | 3,001 | 3,913 | 5,511 | 2,266 |
| Total Current Liabilities | 2,227 | 4,085 | 5,000 | 4,693 | 5,141 | 1,004 |
| Inventory | N/A | 169 | 296 | 279 | 203 | 165 |
| Trade Receivables | 1,738 | 1,875 | 1,342 | 1,577 | 1,485 | 1,806 |
| Trade Payables | 2,186 | 3,573 | 4,422 | 4,063 | 4,561 | 551 |
| Net Working Capital | -471 | -1,441 | -1,999 | -780 | 370 | 1,262 |
| Net Working Capital % of Revenue | -10.1% | -36.5% | -52.5% | -15.9% | 8.6% | 29.8% |
| Trade Working Capital | -448 | -1,529 | -2,784 | -2,207 | -2,873 | 1,420 |
| Trade Working Capital % of Revenue | -9.7% | -38.7% | -73.1% | -44.9% | -67.1% | 33.5% |
| Change in Trade Working Capital | N/A | -1,081 | -1,255 | 577 | -666 | 4,293 |
| Turnover & efficiency | ||||||
| Inventory Turnover | N/A | 12.21x | 8.30x | 11.25x | 14.16x | 18.23x |
| Days Inventory Outstanding (DIO) | N/A | 29.9 | 44.0 | 32.4 | 25.8 | 20.0 |
| Receivables Turnover | 2.67x | 2.11x | 2.84x | 3.12x | 2.88x | 2.35x |
| Days Sales Outstanding (DSO) | 136.7 | 173.3 | 128.5 | 117.0 | 126.6 | 155.4 |
| Payables Turnover | 0.95x | 0.58x | 0.56x | 0.77x | 0.63x | 5.46x |
| Days Payable Outstanding (DPO) | 384.2 | 632.2 | 656.6 | 472.4 | 579.0 | 66.9 |
| Cash Conversion Cycle | -247.5 days | -428.9 days | -484.2 days | -323.0 days | -426.7 days | 108.6 days |
| Asset Turnover | 0.64x | 0.39x | 0.33x | 0.38x | 0.31x | 0.41x |
| Cash flow & dividends | ||||||
| Operating Cash Flow | 1,366 | 1,098 | 536 | 106 | 2 | 155 |
| Free Cash Flow (OCF − Capex proxy) | 7 | 102 | 281 | -6 | -52 | -126 |
| Cash Conversion (OCF / EBITDA) | 69.9% | 79.7% | 64.1% | 8.9% | 0.3% | 26.1% |
| Dividends Declared | N/A | 0 | 0 | 0 | 0 | 0 |
| Dividend Payout Ratio | N/A | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →